Yang Ying, Wei Liuyi, Wang Shizhen, Ke Li, Zhao Huimin, Mao Jing, Li Jie, Mao Zongfu
School of Health Sciences, Wuhan University, Wuhan, China.
Global Health Institute, Wuhan University, Wuhan, China.
Physiother Theory Pract. 2022 Jul;38(7):847-857. doi: 10.1080/09593985.2020.1805834. Epub 2020 Aug 18.
Pursed lip breathing (PLB) and diaphragmatic breathing (DB) are physical therapy interventions frequently adopted by patients with chronic obstructive pulmonary disease (COPD). This systematic review aimed to investigate the effects of PLB combined with DB on pulmonary function and exercise capacity in patients with COPD.
Six databases were searched to collect relevant studies published before August 30, 2019 in English and Chinese. Randomized controlled trials (RCTs) with PLB combined with DB training as the exclusive intervention for COPD were identified. Mean difference (MD) or standardized mean difference (SMD) with 95% confidence interval (CI) was calculated. Heterogeneity was assessed by Cochran's test and statistics.
A total of 15 RCTs were included, involving 1098 patients with COPD (570 in treatment groups and 528 in control groups). Significant improvements were found in forced expiratory volume in 1 s (FEV) (SMD = 0.47, 95% CI = 0.27-0.67, < .001), forced vital capacity (FVC) (SMD = 0.87, 95% CI = 0.59-1.15, < .001), FEV as a proportion of FVC (FEV/FVC) (MD = 8.30, 95% CI = 1.17-15.43, = .02), and 6-min walk test (6MWT) distance (MD = 29.09, 95% CI = 19.35-38.83, < .001).
The intervention of PLB combined with DB effectively promotes pulmonary function and exercise capacity in patients with COPD. The combined application of PLB and DB is an easy and low-cost physical therapy intervention, which should be promoted as a daily essential practice of COPD.
缩唇呼吸(PLB)和膈肌呼吸(DB)是慢性阻塞性肺疾病(COPD)患者经常采用的物理治疗干预措施。本系统评价旨在探讨PLB联合DB对COPD患者肺功能和运动能力的影响。
检索六个数据库,收集2019年8月30日前发表的中英文相关研究。纳入以PLB联合DB训练作为COPD唯一干预措施的随机对照试验(RCT)。计算平均差(MD)或标准化平均差(SMD)及95%置信区间(CI)。采用Cochran's Q检验和I²统计量评估异质性。
共纳入15项RCT,涉及1098例COPD患者(治疗组570例,对照组528例)。1秒用力呼气量(FEV₁)(SMD = 0.47,95%CI = 0.27 - 0.67,P <.001)、用力肺活量(FVC)(SMD = 0.87,95%CI = 0.59 - 1.15,P <.001)、FEV₁占FVC的比例(FEV₁/FVC)(MD = 8.30,95%CI = 1.17 - 15.43,P =.02)和6分钟步行试验(6MWT)距离(MD = 29.09,95%CI = 19.35 - 38.83,P <.001)均有显著改善。
PLB联合DB干预可有效提高COPD患者的肺功能和运动能力。PLB与DB联合应用是一种简便且低成本的物理治疗干预措施,应作为COPD患者日常的基本治疗方法加以推广。